Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 3, Issue 1, Pages 31-38

Role of Toll-like Receptors in Adjuvant-Augmented Immune Therapies

1Department of Microbiology and Immunology, Hokkaido University Graduate School of Medicine, Kita-15, Nishi-7, Kita-ku Sapporo 060-8638, Japan
2Department of Immunogy, Osaka Medical Center for Cancer, Nakamichi 1-3-2, Higashinari-ku, Osaka 537-8511, Japan
3ERATO-JST, Laboratory of Molecular and Developmental Biology, University of Tsukuba, Tennoudai 1-1-1, Tsukuba 305-8577, Japan

Received 3 September 2005

Copyright © 2006 Tsukasa Seya et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Tsukasa Seya, Takashi Akazawa, Tadayuki Tsujita, and Misako Matsumoto, “Role of Toll-like Receptors in Adjuvant-Augmented Immune Therapies,” Evidence-Based Complementary and Alternative Medicine, vol. 3, no. 1, pp. 31-38, 2006.